Dallas/Fort Worth, TX (July 23, 2015) — Neos Therapeutics, Inc. (“Neos” or “the Company”) today announced the pricing of its initial public offering of 4,800,000 shares of common stock at an initial public offering price of $15.00 per share. In addition, Neos has granted the underwriters a 30-day option to purchase up to an additional 720,000 shares of common stock at the initial public offering... (read more)

ATLANTA, July 9, 2015 /PRNewswire/ -- Femasys Inc., a developer of innovative medical devices for the women's healthcare market, announced today that it has secured a term loan facility from Silicon Valley Bank.  Under the loan facility, the company ... (read more)